12:57 PM EDT, 03/14/2024 (MT Newswires) -- UBS attended Thomson Reuters' ( TRI ) Investor Day and left feeling "more bullish". This was due to the reaffirmed FY24 guide, outlined 2025-26 financial framework-accelerating Big 3 [~85% revenue] organic growth-~7.5% in FY24 + ~8.5% YoY medium term, and showcased Gen AI solutions throughout the product stack.

"With integration, launch, and monetization of Gen AI ramping in 2024 we believe both near + long-term guidance likely proves conservative," UBS said. Thomson Reuters ( TRI ) also suggested it likely has a clearer line of sight to Gen AI top + bottom-line impact in H224.

Thomson Reuters ( TRI ) is rated Buy with a US$177 target at UBS.

Price: 211.43, Change: +0.68, Percent Change: +0.32